The House Judiciary Committee's Domestic Relations, Business & Probate Laws Subcommittee convened on March 4, 2025, to discuss the Human Life Protection Act (H.3731), which addresses the complex relationship between obstetricians and their patients in the context of abortion and reproductive health care.

The meeting featured testimony from a physician who emphasized the moral and ethical responsibilities of doctors in treating both mothers and unborn children. The physician expressed concern over the current state of reproductive health care, arguing that many practitioners fail to uphold their ethical obligations, particularly in cases involving the abortion pill, mifepristone. The physician described mifepristone as a dangerous drug, citing anecdotal evidence from patients treated at a crisis pregnancy center, including instances of heavy bleeding and lack of proper medical supervision.

The physician's testimony underscored the belief that the Human Life Protection Act is a necessary intervention by the government to ensure the safety and ethical treatment of patients. The physician thanked the committee for their efforts in advancing the legislation, expressing pride in being a South Carolina physician.

Following the testimony, the committee acknowledged the numerous individuals who had yet to provide public comments, encouraging them to submit their written feedback via email for consideration. Representative McCravey, the primary sponsor of a related bill, was invited to speak, although time constraints limited the discussion.

The meeting concluded with a call for continued public engagement and feedback on the proposed legislation, highlighting the ongoing debate surrounding reproductive health care and the implications of the Human Life Protection Act in South Carolina.